Tagged with EG

Egypt Christelle Saghbini, the newly appointed chairman & managing director of Sanofi for Egypt & Sudan, highlights her strategic roadmap for bringing access to innovative medicines to Egypt. She also explains how Sanofi is a strong partner in the government’s efforts to improve the level of healthcare in the country.  …

China Yan Hao, chairman and CEO of EPS Group shares the company’s journey to become Japan’s largest and most comprehensive provider of optimal outsourced solutions to the healthcare industry through its CRO, SMO and CSO operations. As CEO of EPS Group’s subsidiary company EPS China Group, Yan also outlines the China…

Egypt Ahmed Zaghloul, CEO of October Pharma, stresses the need for better infrastructure for biosimilars in Egypt to stay competitive on a global level. He also highlights October Pharma’s ambitious export strategy, targeting markets in the Gulf Region and South East Asia.   Production costs are rising, and pricing pressures continue,…

Spain Nabil Daoud, president of Lilly Spain, Portugal and Greece, highlights the importance of Lilly’s Spanish operations to the global group; Spain being the only country outside to hold manufacturing, pre-clinical research and commercial sales functionalities. Furthermore, he gives insight into his strategy to deliver the company’s exciting pipeline and his…

Korea Historically, Handok has been the entry point of multinational companies to Korea. Now Handok is reinventing itself as a total healthcare company with global ambitions. Its chairman and CEO, Young-jin Kim, explains how he has continued his father’s legacy while also driving the transition to new product development by following…

Lithuania Ruta Pumputiene examines recent regulatory reform in Lithuania, as the Baltic nation attempts to introduce a holistic HTA mechanism for the evaluation of what to include on the country’s reimbursable medicines list.   It is not yet clear whether the new procedure will complicate and damage Lithuanian patients’ access to…

China Asgar Rangoonwala, president of Xian Janssen, Janssen’s Chinese affiliate, shares the key milestones for the affiliate in the past two years, how Janssen is investing in bringing new innovations to the Chinese market with a phenomenal 14 new products approved in 2018, and their commitment to working with all stakeholders…

Egypt Patrick Tete, managing director of Servier Egypt, highlights the cornerstones of his plan to transform the French company’s Egyptian affiliate, discussing its strengths and its place in Servier’s global operations. He also emphasises the need for more education and awareness amongst the population to reduce the prevalence of cardiovascular diseases…

Korea Nic Horridge was recently appointed president of Roche Korea, having spent an extended period in emerging Asian markets. He shares his vision for the Korean affiliate, focused on bringing Roche’s extensive global pipeline of innovative medicines to Korean patients, making personalized healthcare a reality in clinics and championing Korea as…

Egypt Dr Mohsen Shalaby, President of Nerhadou, explains how he has built Egypt’s leading mineral supplement and nutraceuticals company from scratch within 25 years. He highlights Nerhadou’s innovative solutions and the company’s aspirations to export to overseas markets upon receiving FDA approval.   Nerhadou has been the first mover in the…

Spain Javier Hidalgo, CEO and president of Tedec-Meiji Farma, highlights the main challenges he faces and how he positions the company as the preferred partner of choice. Furthermore, he offers his insights into the strategic importance of Spain for the group and how he blends the two cultures of the company,…

France Bertrand de Lavenne, general manager of Mylan France, explains how the affiliate is positioned within the group’s operations and how the Mylan strategy is to be a key actor in connecting the health network around patient needs. De Lavenne also shares his view on the French pharmaceutical market and the…